Loading
Latest filing published 25 Aug 2026 for Theralase Technologies Inc., €5,742. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Kristina Maria Hachey in Theralase Technologies Inc. In total, 3 filings cover trades dated from 7 August 2026 to 24 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 25 August 2026: an option exercise of €5,742, in Theralase Technologies Inc. The median gap between a trade and its publication by SEDI is 1 day. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations